These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26718267)

  • 1. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1.
    He H; Tian W; Chen H; Deng Y
    Mol Med Rep; 2016 Feb; 13(2):1923-9. PubMed ID: 26718267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
    Jiang C; Long J; Liu B; Xie X; Kuang M
    Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
    Ou Y; Zhai D; Wu N; Li X
    Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
    Yin W; Nie Y; Zhang Z; Xie L; He X
    Oncol Rep; 2015 Jul; 34(1):368-74. PubMed ID: 25997995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
    Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
    Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
    Ragheb MA; Soliman MH; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):237-245. PubMed ID: 32357822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
    Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
    Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.
    Iwai N; Yasui K; Tomie A; Gen Y; Terasaki K; Kitaichi T; Soda T; Yamada N; Dohi O; Seko Y; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Konishi H; Naito Y; Itoh Y
    Int J Oncol; 2018 Jul; 53(1):237-245. PubMed ID: 29658604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.
    Zhang R; Li Y; Dong X; Peng L; Nie X
    Med Oncol; 2014 Dec; 31(12):347. PubMed ID: 25416050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
    Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
    World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
    Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
    J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC).
    Gao B; Gao K; Li L; Huang Z; Lin L
    Biomed Pharmacother; 2014 Mar; 68(2):143-8. PubMed ID: 24183204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.